South Plainfield, NJ, United States of America

Paul Pollara


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 144(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paul Pollara

Introduction

Paul Pollara is an accomplished inventor based in South Plainfield, NJ (US). He has made significant contributions to the field of immunology through his innovative patent. His work focuses on the selective removal of immunospecifically recognizable substances, which has important implications for medical treatments and diagnostics.

Latest Patents

Paul Pollara holds a patent for a process and apparatus designed for the selective removal of immuno-specifically recognizable substances in the form of immune complexes from a solution. This innovative method involves contacting a solution containing preformed immune complexes with an adsorbent made of non-immunospecific factors such as Clq, rheumatoid factor, Fc receptor, and Fc receptor-bearing cells. This patent highlights his expertise in developing solutions that can enhance the efficacy of immunological treatments.

Career Highlights

Throughout his career, Paul Pollara has been associated with Immunicon Corporation, where he has contributed to various projects aimed at advancing immunological research and applications. His work has not only led to the development of new technologies but has also paved the way for further innovations in the field.

Collaborations

Paul Pollara has worked alongside his coworker, Paul A. Liberti, contributing to the collaborative efforts at Immunicon Corporation. Their combined expertise has fostered an environment of innovation and progress within the company.

Conclusion

Paul Pollara's contributions to the field of immunology through his patent and work at Immunicon Corporation demonstrate his commitment to advancing medical science. His innovative approaches continue to influence the development of new treatments and technologies in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…